Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer.
Bidard FC, Ng CK, Cottu P, Piscuoglio S, Escalup L, Sakr RA, Reyal F, Mariani P, Lim R, Wang L, Norton L, Servois V, Sigal B, Vincent-Salomon A, Weigelt B, Pierga JY, Reis-Filho JS.
Bidard FC, et al. Among authors: pierga jy.
Ann Oncol. 2015 Aug;26(8):1704-9. doi: 10.1093/annonc/mdv217. Epub 2015 May 7.
Ann Oncol. 2015.
PMID: 25953157
Free article.